| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.37T | 4.08T | 3.83T | 3.38T | 2.71T |
| Gross Profit | 978.62B | 951.57B | 901.15B | 756.18B | 607.68B |
| EBITDA | 546.07B | 691.39B | 615.52B | 534.71B | 477.14B |
| Net Income | 223.78B | 262.31B | 228.78B | 192.86B | 180.31B |
Balance Sheet | |||||
| Total Assets | 11.19T | 9.40T | 11.08T | 7.82T | 7.63T |
| Cash, Cash Equivalents and Short-Term Investments | 518.74B | 468.20B | 740.21B | 628.30B | 588.43B |
| Total Debt | 1.83T | 1.73T | 1.71T | 1.70T | 1.39T |
| Total Liabilities | 4.34T | 4.39T | 4.93T | 3.89T | 3.61T |
| Stockholders Equity | 6.77T | 4.90T | 6.05T | 3.84T | 3.93T |
Cash Flow | |||||
| Free Cash Flow | 193.87B | -39.45B | 94.66B | -95.01B | 83.71B |
| Operating Cash Flow | 398.79B | 171.58B | 443.59B | 194.96B | 321.08B |
| Investing Cash Flow | -197.08B | -43.40B | 47.90B | -427.64B | -229.81B |
| Financing Cash Flow | -81.50B | -198.65B | -209.49B | 183.69B | -92.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ÂĄ3.43T | 9.91 | 13.26% | 1.85% | 4.26% | 7.71% | |
70 Outperform | ÂĄ6.34T | 41.65 | 4.59% | 0.78% | 6.97% | -12.71% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ÂĄ1.69T | -82.83 | 9.73% | 3.61% | -1.57% | -73.96% | |
56 Neutral | ÂĄ4.91T | 9.73 | 4.09% | 4.41% | -1.94% | -43.84% | |
55 Neutral | ÂĄ635.22B | 6.29 | 1.72% | 4.52% | -2.42% | -93.40% | |
47 Neutral | ¥1.22T | -12.05 | -16.69% | ― | -4.66% | -1038.25% |